Smoore International's stock surged 5.05% during intraday trading, reflecting a significant positive market reaction.

The movement is primarily attributed to the U.S. Food and Drug Administration's (FDA) approval of fruit-flavored e-cigarettes for market sale, marking the first authorization of a non-tobacco flavored vaping product. This signals a favorable shift in regulatory stance, which is expected to benefit the industry.

As a global core atomization supplier, Smoore International is well-positioned to capitalize on this development, having already developed underage-user identification technology. The company's core client products and proprietary brands are anticipated to see accelerated regulatory approvals. Furthermore, Smoore's strong first-quarter financial performance, with revenue up 41.7% year-over-year and adjusted net profit growing 10.7%, driven by recovery in its core vaping business and rapid scaling of its heated tobacco segment, underpins investor confidence.